TransIT®-BrCa transfection reagent offers superior DNA transfection of breast cancer cell types.

• Achieve high expression levels in multiple breast cancer cell types
• Formulated for low cellular toxicity – maintain cell density and reduce experimental bias
• Superior transfection efficiency

TransIT®-BrCa transfection reagent is a dedicated breast cancer cell line specific reagent. While it delivers efficiently to many breast cancer cell types, it also maintains low cellular toxicity resulting in reduced experimental bias. TransIT®-BrCa transfection reagent exhibits higher luciferase expression in breast cancer cells compared to other transfection reagents.